RxPrep Course Book A Comprehensive Course for the NAPLEX� and CPJE (2013 Edition)

(9)
RxPrep Course Book A Comprehensive Course for the NAPLEX� and CPJE (2013 Edition) image
ISBN-10:

0578116073

ISBN-13:

9780578116075

Edition: 2013
Released: Jan 01, 2013
Publisher: RxPrep, Inc.
Format: Paperback, 944 pages
Related ISBN: 9781467596503

Description:

Completely updated for 2013, the RxPrep Course Book is the preferred study guide for students preparing for the NAPLEX(R) exam and/or the CPJE. Features include: Expanded Infectious Diseases; Expanded Common Skin Conditions; Expanded IV Drugs, Fluids, Antidotes; Additional Calculation Practice for Math & Biostatistics; All New Essential Drugs & Updates including COPD, Pain, Weight Loss, and others.Includes practice cases for many major therapeutic topics.

Best prices to buy, sell, or rent ISBN 9780578116075




Frequently Asked Questions about RxPrep Course Book A Comprehensive Course for the NAPLEX� and CPJE (2013 Edition)

You can buy the RxPrep Course Book A Comprehensive Course for the NAPLEX� and CPJE (2013 Edition) book at one of 20+ online bookstores with BookScouter, the website that helps find the best deal across the web. Currently, the best offer comes from and is $ for the .

The price for the book starts from $23.67 on Amazon and is available from 2 sellers at the moment.

If you’re interested in selling back the RxPrep Course Book A Comprehensive Course for the NAPLEX� and CPJE (2013 Edition) book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.

As for the RxPrep Course Book A Comprehensive Course for the NAPLEX� and CPJE (2013 Edition) book, the best buyback offer comes from and is $ for the book in good condition.

The RxPrep Course Book A Comprehensive Course for the NAPLEX� and CPJE (2013 Edition) book is in very low demand now as the rank for the book is 5,281,465 at the moment. A rank of 1,000,000 means the last copy sold approximately a month ago.

Not enough insights yet.